Assess the impact of concentrations of inflammatory markers IL-6, CRP in the presence of albuminuria in patients with type 2 diabetes;Ocena wpływu stȩżenia markerów stanu zapalnego: IL-6, CRP na wystȩpowanie albuminurii u chorych na cukrzycȩ typu 2

Polski Merkuriusz Lekarski

Volumn 32, Issue 188, 2012, Pages 98-102

  Czyzewska, J ^a   Wasilewska, K ^b   Kaminska J ^a   Koper, O ^a   Kemona, H ^a   Jakubowska, I ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Clinical Department of Internal Diseases Endocrinology and Diabetology   (Poland)

Author keywords

Albuminuria; CRP protein; Diabetes mellitus type 2; IL 6

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLYCOSYLATED HEMOGLOBIN; INTERLEUKIN 6;

AGED; ALBUMINURIA; ARTICLE; BLOOD; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; ALBUMINURIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED;

EID: 84858638010     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bhowmick K., Kutty A. V. M., Shetty H. V.: Glycemic control modifites the association between microalbuminuria nad C-reactive protein in type 2 diabetes mell'rtus. Indian J. Clin. Biochem., 2007;22, 53-59. (Pubitemid 350224128)
2. Choudhary N., Ahlawat R. S.: Interteukin-6 and C-reactive protein in pathogenesis of diabetic nephrophaty: New evidence linking inflammation, glycemic control, and microalbuminuria. Iran. J. Kidney Dis., 2008;2, 72-79.
3. Dinarello C. A., Thompson R. C.: Effects of interieukin-1 receptor antagonists in vitro and in vivo. Immunol. Today 1991;12, 404-410.
4. Dronavalli S., Duka I., Bakris G. L.: The pathogenesis of diabetic nephropathy, Nat. Clin. Pract. Endocrinol. Matab., 2008;8, 444-452.
5. Gabay C., Cushner I.: Acute-phase proteins and other systemic response to inflammation. N. Engl. J. Med., 1999;340, 448-454. (Pubitemid 29084777)
6. Ihnat M. A., Thorpe J. E., Ceriello A.: Hypothesis: the metabolic memory, the new challenge of diabetes. Diabet. Med., 2007;24, 582-586. (Pubitemid 46808866)
7. Jerems G., Maclsaac R. J.: Treatment of microalbuminuria in patients with type 2 diabetes mellitus, Treat. Endocrinol., 2002;1, 163-173.
8. Kimura T., Kanada T., Kotajima N. i wsp.: Involvment of circulating interleukin-6 and Us receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction. Eur. J. Endocrinol., 2000;143, 179-184. (Pubitemid 30622350)
9. Kolcowa O., Ortowska-Kunikowska E., Sementkowska-Jurkiewicz E. i wsp.: Ocena wybranych markerów procesu zaplanego u chorych na cukrzycȩ typu 2. Diabetol. Dośw. Klin., 2003;3, 41-46.
10. Koukkunen H., Penttila K., Kemppainen A. i wsp.: C-reactive protein, fibrinogen, interleukin-6 and tumor necrosis factor-Ralpha in the prognostic classification of unstable angina pectoris. Ann. Med., 2001;33, 47-52.
11. Lu B., Yang Y., Yang Z. et al.: Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abnormal obesity, Cardiovasc. Diabetol., 2010;9, 92-98.
12. Marshall S. M.:. Recent advances in diabetic nephropathy, Postgrad. Med. J., 2011;4, 624-633.
13. Nawarro J. F., Mora C., Caca M. i wsp.: Inflammatory process are independently associated with urinary albumin in type 2 diabetes mellitus. Am. J. Kidney Dis., 2003;42, 53-61. (Pubitemid 36807654)
14. Persson F., Rossing P., Havind P. i wsp.: Irbesarian treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substady. Diabetes., 2006;55, 3550-3555. (Pubitemid 44923616)
15. Rosea M. G., Mustafa T. G., Kinter M. T. i wsp.: Glycation of mitochondria proteines from diabetic rat kidney is associated with excess superoxide formation. Am. J. Physiol. Renal Physiol., 2005;289, 1420-1430.
16. Shaw J. E., Sicree R. A., Zimmet P. Z.: Global estimates of the prevalence of diabetes for 2010 and 2030, Diabetes Res. Clin. Pract., 2010;87, 4-14.
17. Shikano M., Sobajima H., Yoshikawa H. i wsp.: Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron., 2000;85, 81-85. (Pubitemid 30242834)
18. SU J. B., Wang X. Q., Qhen J. F. i wsp.: Glycemic variability in insulin treated type 2 diabetes with well-controlled hemoglobin A1c and its response to further treatment with acarbose, Chin. Med. J., 2011;124, 144-147.
19. Tooke J. E.: Patogeneza mikroalbuminurii. Int. J. Metabol., 2009;22, 1-2.
20. Zimmerman B. R.: Postprandial hyperglycemia: implications for practice. Am. J. Cardiol., 2001;88, 32-36.